Mitra Ramgopal
Stock Analyst at Sidoti & Co.
(3.02)
# 1,387
Out of 4,913 analysts
21
Total ratings
73.33%
Success rate
33.14%
Average return
Main Sectors:
Stocks Rated by Mitra Ramgopal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCPC Balchem | Upgrades: Buy | $175 | $150.74 | +16.09% | 6 | Feb 22, 2022 | |
| TRNS Transcat | Upgrades: Buy | $60 | $82.96 | -27.68% | 2 | May 19, 2021 | |
| AMN AMN Healthcare Services | Maintains: Buy | $72 → $70 | $19.67 | +255.87% | 5 | Jun 16, 2020 | |
| ADUS Addus HomeCare | Maintains: Buy | $96 → $115 | $109.11 | +5.40% | 4 | Jun 1, 2020 | |
| USPH U.S. Physical Therapy | Maintains: Buy | $128 → $80 | $75.33 | +6.20% | 1 | Mar 27, 2020 | |
| BEAT HeartBeam | Maintains: Buy | $81 → $75 | $1.30 | +5,669.23% | 3 | Feb 27, 2020 |
Balchem
Feb 22, 2022
Upgrades: Buy
Price Target: $175
Current: $150.74
Upside: +16.09%
Transcat
May 19, 2021
Upgrades: Buy
Price Target: $60
Current: $82.96
Upside: -27.68%
AMN Healthcare Services
Jun 16, 2020
Maintains: Buy
Price Target: $72 → $70
Current: $19.67
Upside: +255.87%
Addus HomeCare
Jun 1, 2020
Maintains: Buy
Price Target: $96 → $115
Current: $109.11
Upside: +5.40%
U.S. Physical Therapy
Mar 27, 2020
Maintains: Buy
Price Target: $128 → $80
Current: $75.33
Upside: +6.20%
HeartBeam
Feb 27, 2020
Maintains: Buy
Price Target: $81 → $75
Current: $1.30
Upside: +5,669.23%